Analysts forecast that Danaher Co. (NYSE:DHR) will announce earnings per share of $1.01 for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for Danaher’s earnings, with the lowest EPS estimate coming in at $1.01 and the highest estimate coming in at $1.02. Danaher posted earnings per share of $0.99 in the same quarter last year, which would indicate a positive year over year growth rate of 2%. The firm is scheduled to issue its next quarterly earnings results on Thursday, April 18th.
According to Zacks, analysts expect that Danaher will report full-year earnings of $4.78 per share for the current financial year, with EPS estimates ranging from $4.50 to $4.83. For the next financial year, analysts expect that the company will report earnings of $5.12 per share, with EPS estimates ranging from $4.40 to $5.28. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that follow Danaher.
Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.01. The firm had revenue of $5.40 billion for the quarter, compared to the consensus estimate of $5.33 billion. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the firm posted $1.19 EPS.
Shares of NYSE DHR traded up $0.08 during trading on Thursday, reaching $111.32. 2,365,723 shares of the company traded hands, compared to its average volume of 2,423,686. The company has a quick ratio of 1.07, a current ratio of 1.47 and a debt-to-equity ratio of 0.34. The company has a market cap of $77.97 billion, a PE ratio of 24.63, a PEG ratio of 2.05 and a beta of 0.99. Danaher has a 52-week low of $94.59 and a 52-week high of $111.82.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 25th. Investors of record on Friday, December 28th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend was Thursday, December 27th. Danaher’s payout ratio is 14.16%.
Several institutional investors and hedge funds have recently bought and sold shares of DHR. Oregon Public Employees Retirement Fund boosted its holdings in shares of Danaher by 10,085.3% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,863,048 shares of the conglomerate’s stock worth $67,000 after buying an additional 6,795,666 shares during the last quarter. FMR LLC boosted its holdings in shares of Danaher by 10.3% in the second quarter. FMR LLC now owns 21,011,026 shares of the conglomerate’s stock worth $2,073,369,000 after buying an additional 1,963,116 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Danaher by 87.4% in the third quarter. Renaissance Technologies LLC now owns 3,219,500 shares of the conglomerate’s stock worth $349,831,000 after buying an additional 1,501,300 shares during the last quarter. Findlay Park Partners LLP boosted its holdings in shares of Danaher by 25.0% in the fourth quarter. Findlay Park Partners LLP now owns 4,595,000 shares of the conglomerate’s stock worth $473,836,000 after buying an additional 920,000 shares during the last quarter. Finally, 1832 Asset Management L.P. boosted its holdings in shares of Danaher by 74.3% in the fourth quarter. 1832 Asset Management L.P. now owns 2,129,142 shares of the conglomerate’s stock worth $219,310,000 after buying an additional 907,593 shares during the last quarter. 77.79% of the stock is currently owned by institutional investors.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Further Reading: Day Trading
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.